Parol suspension

Form: Suspension
Dosage: 100ml
Packaging: Suspension of 100 ml

Active substance: paracetamol

Form: Oral suspension

Dosage: Each ml of Parol suspension contains 50 mg of paracetamol (250 mg/5ml)

this concentration is higher than most competitors. This makes it easier to take.


Packaging: Bottle with 100 ml   – strawberry taste


Target: children (from infants) up to 6 years

Parol suspension can also be used by older children and even adults. You just have to adapt the dosage

Parol suspension is indicated for the relief of mild to moderate pain and for reducing fever in children

Parol suspension is used for the symptomatic treatment of acute or chronic pain: headache, toothache, dysmenorrhea, migraine, myalgia, neuralgia, post-traumatic pain, post-operative pain and musculoskeletal pain.

Parol suspension can also be used as an antipyretic and painkiller in cases of flu, colds, sore throat, sinusitis, and other acute febrile conditions.

The recommended daily dose of paracetamol is about 60 mg/kg/day, divided into 4 or 6 doses, i.e. about 15 mg/kg every 6 hours or 10 mg/kg every 4 hours.

The maximum daily dose should not be exceeded.

Over-the-counter drug

Notice of Trademark Infringement

Dear valued partners, customers and Dafra representatives,

It has come to our attention that unauthorized use of our company’s name and logo has been observed in various contexts in the African country Togo ( In order to avoid misunderstandings, ever misleading, we feel it is imperative to address this issue promptly and transparently.

Trademark infringement poses a significant threat not only to our brand integrity but also to the trust and credibility we have worked diligently to establish within our community. Our name and logo represent our values, quality, and commitment to excellence, and any unauthorized use undermines these principles.

We take trademark infringement seriously and are actively taking measures to address any instances of unauthorized use. This includes legal action against parties found to be infringing upon our intellectual property rights.

We urge our customers, partners, African representatives and the general public to remain vigilant and report any suspected instances of trademark infringement directly to us. Your cooperation in this matter is crucial in helping us protect our brand and preserve the integrity of our business.

As always, we remain dedicated to providing high quality medical solutions in the sub-Sahara region of Africa and maintaining the highest standards of integrity and professionalism.

Thank you for your continued support and trust in our company.

Dafra Pharma